You just read:

Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation

News provided by

Achieve Life Sciences, Inc.

Oct 30, 2018, 05:30 ET